Barclays Maintains an 'Overweight' on Agilent (A); Strong Guidance Lifts Overhang

Barclays maintains an 'Overweight' on Agilent (NYSE: A) price target raised $4 to $48.

Barclays analyst says, "Agilent saw Q4 sales of $1.73B (cons. $1.75B) and EPS of $0.84 (cons. $0.81). Organic sales growth was +7% y/y (EMG +10%, LSG +6%, CAG +1%). Ex-FX order growth was +2% y/y and Book/Bill was 1.01 (EMG 0.96, LSG 1.08, and CAG 1.04). Agilent guided 2012 ahead of expectations, with revenues of $6.85B-7.15B (cons $6.97B) and EPS range of $3.00-3.35 (cons $3.14)." (Barclays raises FY12 EPS estimate from $3.15 to $3.22)

For an analyst ratings summary and ratings history on Agilent click here. For more ratings news on Agilent click here.

Shares of Agilent closed at $38.25 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Agilent (A) PT Raised to $150 at Jefferies
• Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer
• Implantica receives FDA approval for RefluxStop® - Opening the U.S. market